The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Utility of FDG-PET/CT in lymphoma patients undergoing immunotherapy with autologous CTL019 T-cells.
 
Nirav Niranjan Shah
Stock and Other Ownership Interests - Exelixis; Geron; OncoSec
 
Drew A. Torigian
No Relationships to Disclose
 
Michael Farwell
No Relationships to Disclose
 
Wei-Ting Hwang
No Relationships to Disclose
 
Noelle V. Frey
No Relationships to Disclose
 
Sunita Nasta
Research Funding - Takeda
 
Daniel Jeffrey Landsburg
No Relationships to Disclose
 
Anthony R. Mato
No Relationships to Disclose
 
Carl H. June
Consulting or Advisory Role - Novartis
Research Funding - Novartis
Patents, Royalties, Other Intellectual Property - Novartis
 
Stephen J. Schuster
Consulting or Advisory Role - Celgene; Pharmacyclics
Research Funding - Celgene (Inst); Gilead Sciences (Inst); Johnson & Johnson (Inst); Novartis (Inst); Pharmacyclics (Inst)
 
David L. Porter
Employment - Genentech/Roche (I)
Stock and Other Ownership Interests - Celgene
Research Funding - Novartis
Patents, Royalties, Other Intellectual Property - Patent/royalty rights
 
Jakub Svoboda
Research Funding - Celgene; MedImmune; Seagen